back insurance patient resources covid-19 response request records first visit info common clinical fees billing inquiries pay bill

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Rajeev Vibhakar, MD, PhD, MPH/MSPH

Pediatric Hematology / Oncology

Board Certified

Schedule Appointment

Locations

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave Aurora, CO 80045

720-777-1234

Provider Expertise

Clinical Interest for Patients

My clinical interest is in the treatment of Pediatric Oncology & Neuro-Oncology with an emphasis on medulloblastoma.


Specialties

  • Pediatrics ( 2011 )
  • Pediatric Hematology / Oncology ( 2008 )

Conditions & Treatments

  • Cancers

    Pediatric Cancer

  • Blood / Lymphatic System

    Blood Disorders

Education & Training

Medical Schools

MD, New York Medical College (1999)


Undergraduate Schools

BA, Macalester College (MN) (1991)


Graduate Schools

PhD, New York Medical College (1999)

MPH, New York Medical College (1999)


Residency Program

University of Iowa Hospitals and Clinics Program (2002)


Fellowships

University of Iowa Hospitals and Clinics Program (2005)

Professional Memberships

American Association of Cancer Research, Member


American Society for Gene Therapy, Member


American Society for Pediatric Hematology/Oncology, Member


Society for Neuro-Oncology, Member


Research & Grants

Research Interests for Patients

My research focuses on genetic mechanisms by which normal brain cells become cancerous and how these genetic differences can be used to better diagnose and treat children with brain tumors.

information for referring providers

Referral Contact Phone

(720) 777-6740

Clinical Interests for Referring Providers

My clinical interest is in the treatment of Pediatric Oncology & Neuro-Oncology with an emphasis on medulloblastoma.

Research Interest for Referring Providers

My research focuses on genetic mechanisms by which normal brain cells become cancerous and how these genetic differences can be used to better diagnose and treat children with brain tumors.